JNJ on the beat

the last time i posted was about when it hit the last low of around 152/151.5

just posting an update, seems to be coming back into the buy area, and the next price target would be around 162 if a full run were to happen

$spy on the other hand... still remaining under 400 is scary and fed announcements coming next week, this will determine how the next quarter will project but as it sits right now its not a bad position

Comentário:

i did want to additionally point out that macd has crossed the second time, which on the chart has consistently been an up swing

as well as RSI being... ungodly low for a while.

the whole pharmaceutical sector, even cvs and pfizer have all been on a down trend the last quarter, even with better earnings reports and estimates for the upcoming quarter